High baseline tau and ISR activation may lower the effective trazodone threshold, making biomarker-defined subgroups more responsive

Target: MAPT; EIF2AK3; EIF2S1; ATF4 Composite Score: 0.510 Price: $0.50 Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
⚠ Missing Evidence⚠ Low Validation⚠ Orphaned Senate Quality Gates →
Quality Report Card click to collapse
C+
Composite: 0.510
Top 74% of 1402 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
B Mech. Plausibility 15% 0.63 Top 54%
C+ Evidence Strength 15% 0.50 Top 65%
B Novelty 12% 0.60 Top 74%
C Feasibility 12% 0.48 Top 69%
C+ Impact 12% 0.58 Top 69%
C+ Druggability 10% 0.52 Top 59%
D Safety Profile 8% 0.36 Top 88%
C+ Competition 6% 0.55 Top 72%
C Data Availability 5% 0.46 Top 79%
C Reproducibility 5% 0.42 Top 83%
Evidence
3 supporting | 3 opposing
Citation quality: 0%
Debates
0 sessions
No debates yet
Convergence
0.00 F 30 related hypothesis share this target

Description

Patients with elevated p-tau and ISR activation may require less trazodone exposure to show pharmacodynamic effects because the drug acts on an already engaged pathogenic node. The best use of this idea is as a stratification hypothesis nested within dose-finding studies rather than as a standalone efficacy thesis.

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["MAPT/Tau Protein
Microtubule Stabilizer"] B["CDK5/GSK3B Activation
Kinase Dysregulation"] C["Tau Hyperphosphorylation
Ser396/Thr231/Ser202"] D["Tau Detachment
Microtubule Destabilized"] E["Tau Oligomers
Paired Helical Filaments"] F["Neurofibrillary Tangles
Intraneuronal Inclusions"] G["Axonal Transport Failure
Synaptic Dysfunction"] H["Neurodegeneration
Tauopathy Spread"] A --> B B --> C C --> D D --> E E --> F D --> G G --> H F --> H style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7 style C fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.63 (15%) Evidence 0.50 (15%) Novelty 0.60 (12%) Feasibility 0.48 (12%) Impact 0.58 (12%) Druggability 0.52 (10%) Safety 0.36 (8%) Competition 0.55 (6%) Data Avail. 0.46 (5%) Reproducible 0.42 (5%) KG Connect 0.50 (8%) 0.510 composite
6 citations 6 with PMID Validation: 0% 3 supporting / 3 opposing
For (3)
No supporting evidence
No opposing evidence
(3) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
2
4
MECH 2CLIN 4GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Phosphorylated eIF2alpha is enriched in tau-positi…SupportingMECH----PMID:12499843-
PERK pathway inhibition prevents tau-mediated neur…SupportingCLIN----PMID:26450683-
Trazodone reduced tau-linked neurodegeneration in …SupportingMECH----PMID:28430857-
High p-tau and high ISR activation may instead mar…OpposingCLIN----PMID:26450683-
No human evidence currently shows that biomarker-h…OpposingCLIN----PMID:35921312-
Apparent subgroup effects could reflect regression…OpposingCLIN----PMID:12499843-
Legacy Card View — expandable citation cards

Supporting Evidence 3

Phosphorylated eIF2alpha is enriched in tau-positive degenerating neurons, linking ISR activation to tau patho…
Phosphorylated eIF2alpha is enriched in tau-positive degenerating neurons, linking ISR activation to tau pathology.
PERK pathway inhibition prevents tau-mediated neurodegeneration in preclinical systems, supporting pathway dep…
PERK pathway inhibition prevents tau-mediated neurodegeneration in preclinical systems, supporting pathway dependence in tauopathy.
Trazodone reduced tau-linked neurodegeneration in mouse models.

Opposing Evidence 3

High p-tau and high ISR activation may instead mark more advanced, less reversible disease rather than greater…
High p-tau and high ISR activation may instead mark more advanced, less reversible disease rather than greater dose sensitivity.
No human evidence currently shows that biomarker-high patients respond at lower trazodone doses.
Apparent subgroup effects could reflect regression to the mean or larger biomarker dynamic range rather than t…
Apparent subgroup effects could reflect regression to the mean or larger biomarker dynamic range rather than true threshold lowering.
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

No linked debates yet. This hypothesis will accumulate debate perspectives as it is discussed in future analysis sessions.

Price History

0.500.510.52 0.53 0.49 2026-04-252026-04-252026-04-25 Market PriceScoreevidencedebate 1 events
7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
1

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (4)

Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease.
Neuroreport (2003) · PMID:12499843
No extracted figures yet
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia.
Acta neuropathologica (2016) · PMID:26450683
No extracted figures yet
Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice.
Brain : a journal of neurology (2017) · PMID:28430857
No extracted figures yet
Trazodone and patient outcomes in dementia-Limitations of naturalistic cohort data.
International journal of geriatric psychiatry (2022) · PMID:35921312
No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (0)

No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
31.7th percentile (747 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
0

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.560

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

Related Hypotheses

LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target
Score: 7.200 | neurodegeneration
Enteric Nervous System Dysfunction as Self-Reinforcing Pathological Loop
Score: 7.000 | neurodegeneration
Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propagation
Score: 6.000 | neurodegeneration
SCFA Deficiency Disrupts Microglial Homeostasis and Promotes Neurodegeneration
Score: 5.500 | neurodegeneration
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration
Score: 0.990 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

3D Protein Structure

🧬 MAPT; — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for MAPT; structures...
Querying Protein Data Bank API

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)